Solutions

Specialty Market Data

Close-Up International collects different Specialty Products Data in various countries, to help customers understand this important growing market. Rx and Sales data, Longitudinal data, Real World Data and other sources are part of our intelligence to the Non-Retail and Specialty Market. 

Understand our Specialty Market
Data solutions

The Specialty Drugs Tracking tool is designed to offer comprehensive insights into product performance within the specialty market

  • Analysis segmented by indication and treatment line across more than 10 therapeutic areas.
  • This tool enables detailed exploration of market size, potential, and product-specific metrics such as market share, drug indication, sequencing of treatments, and treatment duration.
  • Provides valuable data on the funding sources for drugs, including monitoring the impact of private payers, offering a robust platform for tracking and optimizing market strategies for specialty pharmaceuticals.
 
Obtain a quantitative vision of the market and perform a comparative analysis of its behavior and of your products. Click here to learn more.
The Specialty Care Audit tool offers a detailed view of HCPs behavior in the Hospital and Institutional market.
  • The tool offers a detailed market definition by tracking medications that target specific pathologies, whether by brand or active ingredient.
  • This market can be customized to meet the unique needs of clients, with sales data captured from specialized distributors and deliveries.
  • By leveraging precise sales information from key distribution channels, the tool provides comprehensive insights into the performance of specialty care medications, allowing for tailored market analysis and strategic decision-making.
 
Specialty Care Audit is the ideal tool to target and follow performance of your promotional efforts in the Specialty Drugs Market.
Click here to learn more.
In response to the rapid advancements in big data technologies and the increasing relevance of Real World Data (RWD), Close-Up has refined its processes to manage and utilize these data sources efficiently.

With a strong foundation in handling proprietary datasets, Close-Up has heavily invested in RWD platforms designed to collect, access, clean, curate, harmonize, link, and de-identify data, ensuring compliance and generating high-quality evidence for research and analysis.

Longitudinal Prescription Data

Close-Up’s longitudinal prescription data offers a detailed view of patient treatment pathways, capturing how therapies evolve over time. Data is gathered from anonymized patient-level prescription records sourced directly from retail pharmacies and coding centers. The information is typically updated on a monthly or quarterly basis, providing valuable insights into prescription trends and changes.

Claims Data

Close-Up collects adjudicated and pre-adjudicated claims from payers and healthcare providers, covering a wide range of care settings. These claims datasets, sourced from health insurers and providers, are crucial for understanding the financial and care aspects of treatment. The update frequency for claims data varies, ranging from monthly to annually, depending on the dataset.

Hospital Data

Close-Up’s hospital data provides in-depth insights into patient care during hospital visits and stays. This data is sourced from hospital administrative systems, such as the Minimum Basic Data Set (MBDS), either directly from hospitals or via third-party providers. The hospital datasets offer a detailed view of administrative and accounting activities and are updated at intervals ranging from monthly to yearly.

Oncology Data

Close-Up gathers anonymized oncology patient data from specialists, detailing clinical treatments and outcomes. This data is sourced directly from oncology professionals, whether they are based in hospitals, oncology centers, or clinics, through physician software or web-based surveys. Oncology data is updated at frequencies ranging from monthly to quarterly, depending on the data source, providing essential insights into cancer treatment patterns and trends.

Through these advanced data management capabilities, Close-Up delivers high-quality, timely, and compliant datasets that drive meaningful insights across various healthcare sectors. Click here to learn more.

Since our foundation in 1968, we have contributed to the knowledge of market trends, helping, with efficiency and transparency, to strengthen the relationships between laboratories and medical professionals.

Learn more about our Speciality Market Data Solutions.

Discover how Close-Up International’s Speciality Market Data Solutions can help you evaluate your product performance with our advanced tools.

Our services allow you to track every aspect of your promotional actions, providing insights from the initial campaign to the prescriptions made by health professionals.

By closely monitoring your promotional efforts, you can gain a deeper understanding of their impact and effectiveness.

Analyze the results of your promotional strategies with precision using our comprehensive metrics.

Our tools enable you to see the direct correlation between your efforts and the prescriptions generated.

Contact us today to learn more about how Close-Up International can enhance your market strategy and drive your success.

Request a demo now to speak with an expert.

Fill out the form below.

Close-Up International (commercially known as “Close Up”) is the data controller responsible for the processing of your personal data, which will be processed for the purpose of managing and responding to your request, inquiry, or comment.

You may exercise your rights (access, rectification, erasure, objection, restriction of processing, and data portability) and contact us through the Data Protection section of our website (by selecting the corresponding country) or by using the contact address indicated for your country.

For more information on the processing of your data, including the legal basis, recipients, retention periods, and other relevant details, please consult our Privacy Policy.